*Forget the past price - look at the present setup & current discount after a beating. Technical breakout + deep value + dense 2026 catalyst stack. Use a stop loss below recent lows.* **THE TECHNICAL SETUP** IDK is up approximately …
$AIB is not having any social media presence and low key rock and rolling and getting stuff done. Focussed on the business Here is a quick overview of their all star management. Name me a stronger team on any AI …
\- GCTS develops modem + RFICs for 4G/5G and IoT devices \- Small-cap stock (\~$214M Market Cap) → if the 5G + satellite narrative gains traction, it could rally hard \- Strategic deals: orders from Alphachips and partnerships with satellite …
I am not a bear in the current market, per se. But I do think we are coming due for some kind of correction in the mid-term, as the trajectory of the overall market is, in my opinion, untenable. Even …
PG&E filed for bankruptcy in 2019 over wildfire liability. Now Hawaiian Electric has settled a $47.75M investor lawsuit over the Lahaina fire. The pattern is becoming hard to ignore. The case isn't complicated: $HE spent five years, 2019 to 2023, …
[BigBear.ai](http://BigBear.ai) and ISC launched their first AI-powered cargo security platform with Panama Transshipment Group, using biometrics, analytics, and chain-of-custody data to secure Panama’s Dry Canal logistics and aid customs risk detection. Just so you guys know how bullish this is. …
I started looking into RZLV recently and decided to take a small position after reading about the company’s AI-focused retail/ecommerce strategy. What caught my attention was their attempt to integrate AI-driven personalization and shopping tools into online retail experiences, which …
Three catalysts remaining this year, each with a different weight: **1. FDA IND Clearance — Expected Q2 2026** Allows Phase 2 to include US clinical sites. This is largely administrative at this stage — IND clearance for a drug that's …
Most of the GANX thesis lives or dies on GT-02287. Here's a clear-eyed look at what the clinical data actually shows versus what's still unproven. **What's been demonstrated so far in Phase 1b:** Central nervous system target engagement — meaning …
$MNKD currently has 2 products with excellent chances of FDA approval in May & July this year 1. FUROSCIX ReadyFlow Autoinjector PDUFA: July 26, 2026 2. Afrezza Pediatric Indication PDUFA: May 29, 2026 The stock took a major drop in …